ID

13640

Descripción

Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities; ODM derived from: https://clinicaltrials.gov/show/NCT00001568

Link

https://clinicaltrials.gov/show/NCT00001568

Palabras clave

  1. 22/2/16 22/2/16 -
Subido en

22 de febrero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Colorectal Neoplasm NCT00001568

Eligibility Colorectal Neoplasm NCT00001568

Criteria
Descripción

Criteria

rising serum cea levels greater than 6 on two successive tests.
Descripción

cea levels

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201933
resectable residual or recurrent disease. patients in the occult arm (arm 1) must have no visible residual disease in the abdomen at the time of the last surgical exploration. in addition, there must be no imageable definitive site of recurrent disease using conventional imaging modalities including; ct scan of chest/ abdomen/ pelvis with contrast, mri scan, and chest x-ray. patients in arm 2 may have a single site of recurrent or metastatic disease which is resectable but in whom additional sites of disease are not known and no imageable disease other than a solitary site of potentially resectable disease is identified.
Descripción

Surgery, residual or recurrent disease, criteria for study groups

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038894
UMLS CUI [2]
C0543478
UMLS CUI [3]
C0277556
UMLS CUI [4]
C0027627
patients must have an ecog performance status of 0-1.
Descripción

ecog performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
patients must be willing to return to nih for follow-up.
Descripción

return to nih for follow-up

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1321605
patients must be able to provide informed consent as demonstrated by the signed consent.
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
patients must be 2 or more months from abdominal or thoracic surgery.
Descripción

surgery

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038894
no patients with medical contraindication to abdominal exploration.
Descripción

abdominal exploration

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085704
no patients with recurrent disease detected by conventional imaging studies as outlined above. metastatic disease localized outside of the abdominal cavity by conventional imaging studies as outlined above. patients must weigh less than 136 kgs. which is the weight limit for the scanner tables.
Descripción

recurrent disease, metastatic disease outside of the abdominal cavity, body weight

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0277556
UMLS CUI [2]
C0027627
UMLS CUI [3]
C0005910
no patients with previous injection of murine monoclonal antibodies: human anti-mouse assay (hama) will be performed in patients with prior history of receiving murine monoclonal antibodies.
Descripción

prior murine monoclonal antibodies, hama test will be performed

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2916903
UMLS CUI [2]
C1868744
no patients that are pregnant or breast feeding.
Descripción

pregnant or breast feeding

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
patients who are hiv + will be excluded.
Descripción

hiv

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019682

Similar models

Eligibility Colorectal Neoplasm NCT00001568

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
cea levels
Item
rising serum cea levels greater than 6 on two successive tests.
boolean
C0201933 (UMLS CUI [1])
Surgery, residual or recurrent disease, criteria for study groups
Item
resectable residual or recurrent disease. patients in the occult arm (arm 1) must have no visible residual disease in the abdomen at the time of the last surgical exploration. in addition, there must be no imageable definitive site of recurrent disease using conventional imaging modalities including; ct scan of chest/ abdomen/ pelvis with contrast, mri scan, and chest x-ray. patients in arm 2 may have a single site of recurrent or metastatic disease which is resectable but in whom additional sites of disease are not known and no imageable disease other than a solitary site of potentially resectable disease is identified.
boolean
C0038894 (UMLS CUI [1])
C0543478 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
C0027627 (UMLS CUI [4])
ecog performance status
Item
patients must have an ecog performance status of 0-1.
boolean
C1520224 (UMLS CUI [1])
return to nih for follow-up
Item
patients must be willing to return to nih for follow-up.
boolean
C1321605 (UMLS CUI [1])
informed consent
Item
patients must be able to provide informed consent as demonstrated by the signed consent.
boolean
C0021430 (UMLS CUI [1])
surgery
Item
patients must be 2 or more months from abdominal or thoracic surgery.
boolean
C0038894 (UMLS CUI [1])
abdominal exploration
Item
no patients with medical contraindication to abdominal exploration.
boolean
C0085704 (UMLS CUI [1])
recurrent disease, metastatic disease outside of the abdominal cavity, body weight
Item
no patients with recurrent disease detected by conventional imaging studies as outlined above. metastatic disease localized outside of the abdominal cavity by conventional imaging studies as outlined above. patients must weigh less than 136 kgs. which is the weight limit for the scanner tables.
boolean
C0277556 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
C0005910 (UMLS CUI [3])
prior murine monoclonal antibodies, hama test will be performed
Item
no patients with previous injection of murine monoclonal antibodies: human anti-mouse assay (hama) will be performed in patients with prior history of receiving murine monoclonal antibodies.
boolean
C2916903 (UMLS CUI [1])
C1868744 (UMLS CUI [2])
pregnant or breast feeding
Item
no patients that are pregnant or breast feeding.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
hiv
Item
patients who are hiv + will be excluded.
boolean
C0019682 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial